Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
10 Oct 2026

Vaxcyte, Inc. reported A material agreement

Vaxcyte, Inc. filed an 8-K covering a material agreement, a material financing obligation, another company event, supporting financial statements or exhibits.

5 Oct 2026

Vaxcyte, Inc. reported Regulation FD disclosure

Vaxcyte, Inc. filed an 8-K covering Regulation FD disclosure, another company event, supporting financial statements or exhibits.

4 Sep 2026

Vaxcyte, Inc. reported A director or senior management change or compensation event

Vaxcyte, Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

11 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Vaxcyte, Inc..

7 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Vaxcyte, Inc..

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$183.19M
Total assets (USD)$3.14B
Total liabilities (USD)$380.21M
Shareholders' equity (USD)$2.76B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
Verified Financial Statements Unavailable
Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Buy
Target: $117.30
85.5% upside potential
📈
Strong Buy
Unavailable
👍
Buy
8
⏸️
Hold
1
📉
Sell
0
9 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 75.00–163.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
5
Oct 2026
Wassil Jim
EVP, Chief Scientific Ofc, COO
Option exercise
$5.35 per share
18,000 shares
SEC Form 4
5
Oct 2026
Wassil Jim
EVP, Chief Scientific Ofc, COO
Open-market sale
$86.74 per share
18,000 shares
SEC Form 4
5
Oct 2026
Cowan Elvia
SVP, Finance & CAO
Option exercise
$25.92 per share
19,000 shares
SEC Form 4
5
Oct 2026
Cowan Elvia
SVP, Finance & CAO
Open-market sale
$86.74 per share
19,000 shares
SEC Form 4
1
Oct 2026
Wassil Jim
EVP, Chief Scientific Ofc, COO
Option exercise
$5.35 per share
2,250 shares
SEC Form 4
1
Oct 2026
Wassil Jim
EVP, Chief Scientific Ofc, COO
Open-market sale
$56.67 per share
2,250 shares
SEC Form 4
9
Sep 2026
Wassil Jim
EVP, Chief Scientific Ofc, COO
Open-market sale
$59.52 per share
1,334 shares
SEC Form 4
8
Sep 2026
PICKERING GRANT
Director, CHIEF EXECUTIVE OFFICER
Tax withholding
$60.36 per share
17,056 shares
SEC Form 4
8
Sep 2026
GUGGENHIME ANDREW
PRESIDENT AND CFO
Tax withholding
$60.36 per share
7,155 shares
SEC Form 4
8
Sep 2026
Dhaliwal Harpreet S.
Chief Technical Ops Officer
Tax withholding
$60.36 per share
7,651 shares
SEC Form 4

Top Shareholders

Fmr Llc
20,852,907 shares
26.436% change
6/30/2026
Jupiter Topco Llc
17,965,847 shares
New% change
6/30/2026
Janus Henderson Group Ltd.
16,575,875 shares
23.819% change
3/31/2026
T. Rowe Price Investment Management, Inc.
12,207,450 shares
0.672% change
6/30/2026
Vanguard Group Inc
12,193,986 shares
-1.026% change
12/31/2025
Blackrock, Inc.
12,068,129 shares
9.992% change
6/30/2026
Ra Capital Management, L.P.
11,474,599 shares
0% change
6/30/2026
Wellington Management Group Llp
7,001,565 shares
24.703% change
6/30/2026
Vanguard Portfolio Management Llc
6,593,551 shares
5% change
6/30/2026
Vanguard Capital Management Llc
6,348,679 shares
1.308% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 6 hours ago